252 related articles for article (PubMed ID: 27717277)
1. Ultra high risk status and transition to psychosis in 22q11.2 deletion syndrome.
Schneider M; Armando M; Pontillo M; Vicari S; Debbané M; Schultze-Lutter F; Eliez S
World Psychiatry; 2016 Oct; 15(3):259-265. PubMed ID: 27717277
[TBL] [Abstract][Full Text] [Related]
2. Adolescents at ultra-high risk for psychosis with and without 22q11 deletion syndrome: a comparison of prodromal psychotic symptoms and general functioning.
Armando M; Girardi P; Vicari S; Menghini D; Digilio MC; Pontillo M; Saba R; Mazzone L; Lin A; Klier CM; Schäfer MR; Amminger GP
Schizophr Res; 2012 Aug; 139(1-3):151-6. PubMed ID: 22627123
[TBL] [Abstract][Full Text] [Related]
3. No age effect in the prevalence and clinical significance of ultra-high risk symptoms and criteria for psychosis in 22q11 deletion syndrome: Confirmation of the genetically driven risk for psychosis?
Armando M; Schneider M; Pontillo M; Vicari S; Debbané M; Schultze-Lutter F; Eliez S
PLoS One; 2017; 12(4):e0174797. PubMed ID: 28406913
[TBL] [Abstract][Full Text] [Related]
4. Prevalence, course and psychosis-predictive value of negative symptoms in 22q11.2 deletion syndrome.
Schneider M; Armando M; Schultze-Lutter F; Pontillo M; Vicari S; Debbané M; Eliez S
Schizophr Res; 2019 Apr; 206():386-393. PubMed ID: 30414720
[TBL] [Abstract][Full Text] [Related]
5. [Detection and early treatment of subjects at high risk of clinical psychosis: Definitions and recommendations].
Michel C; Toffel E; Schmidt SJ; Eliez S; Armando M; Solida-Tozzi A; Schultze-Lutter F; Debbané M
Encephale; 2017 May; 43(3):292-297. PubMed ID: 28347521
[TBL] [Abstract][Full Text] [Related]
6. Adolescents at ultra-high risk of psychosis in Italian neuropsychiatry services: prevalence, psychopathology and transition rate.
Pelizza L; Azzali S; Garlassi S; Paterlini F; Scazza I; Chiri LR; Pupo S; Raballo A
Eur Child Adolesc Psychiatry; 2018 Jun; 27(6):725-737. PubMed ID: 29058115
[TBL] [Abstract][Full Text] [Related]
7. Cortical Morphology Differences in Subjects at Increased Vulnerability for Developing a Psychotic Disorder: A Comparison between Subjects with Ultra-High Risk and 22q11.2 Deletion Syndrome.
Bakker G; Caan MW; Vingerhoets WA; da Silva-Alves F; de Koning M; Boot E; Nieman DH; de Haan L; Bloemen OJ; Booij J; van Amelsvoort TA
PLoS One; 2016; 11(11):e0159928. PubMed ID: 27828960
[TBL] [Abstract][Full Text] [Related]
8. Distinct white-matter aberrations in 22q11.2 deletion syndrome and patients at ultra-high risk for psychosis.
Bakker G; Caan MW; Schluter RS; Bloemen OJ; da Silva-Alves F; de Koning MB; Boot E; Vingerhoets WA; Nieman DH; de Haan L; Booij J; van Amelsvoort TA
Psychol Med; 2016 Aug; 46(11):2299-311. PubMed ID: 27193339
[TBL] [Abstract][Full Text] [Related]
9. Cortical morphology development in patients with 22q11.2 deletion syndrome at ultra-high risk of psychosis.
Padula MC; Schaer M; Armando M; Sandini C; Zöller D; Scariati E; Schneider M; Eliez S
Psychol Med; 2018 Oct; 48(14):2375-2383. PubMed ID: 29338796
[TBL] [Abstract][Full Text] [Related]
10. Baseline differences in clinical symptomatology between ultra high risk subjects with and without a transition to psychosis.
Velthorst E; Nieman DH; Becker HE; van de Fliert R; Dingemans PM; Klaassen R; de Haan L; van Amelsvoort T; Linszen DH
Schizophr Res; 2009 Apr; 109(1-3):60-5. PubMed ID: 19272756
[TBL] [Abstract][Full Text] [Related]
11. Checking the predictive accuracy of basic symptoms against ultra high-risk criteria and testing of a multivariable prediction model: Evidence from a prospective three-year observational study of persons at clinical high-risk for psychosis.
Hengartner MP; Heekeren K; Dvorsky D; Walitza S; Rössler W; Theodoridou A
Eur Psychiatry; 2017 Sep; 45():27-35. PubMed ID: 28728092
[TBL] [Abstract][Full Text] [Related]
12. Neurocognition as a predictor of transition to psychotic disorder and functional outcomes in ultra-high risk participants: Findings from the NEURAPRO randomized clinical trial.
Bolt LK; Amminger GP; Farhall J; McGorry PD; Nelson B; Markulev C; Yuen HP; Schäfer MR; Mossaheb N; Schlögelhofer M; Smesny S; Hickie IB; Berger GE; Chen EYH; de Haan L; Nieman DH; Nordentoft M; Riecher-Rössler A; Verma S; Thompson A; Yung AR; Allott KA
Schizophr Res; 2019 Apr; 206():67-74. PubMed ID: 30558978
[TBL] [Abstract][Full Text] [Related]
13. Attenuated psychotic and basic symptom characteristics in adolescents with ultra-high risk criteria for psychosis, other non-psychotic psychiatric disorders and early-onset psychosis.
Lo Cascio N; Saba R; Hauser M; Vernal DL; Al-Jadiri A; Borenstein Y; Sheridan EM; Kishimoto T; Armando M; Vicari S; Fiori Nastro P; Girardi P; Gebhardt E; Kane JM; Auther A; Carrión RE; Cornblatt BA; Schimmelmann BG; Schultze-Lutter F; Correll CU
Eur Child Adolesc Psychiatry; 2016 Oct; 25(10):1091-102. PubMed ID: 26921232
[TBL] [Abstract][Full Text] [Related]
14. Testing the Ultra High Risk (prodromal) criteria for the prediction of psychosis in a clinical sample of young people.
Yung AR; Stanford C; Cosgrave E; Killackey E; Phillips L; Nelson B; McGorry PD
Schizophr Res; 2006 May; 84(1):57-66. PubMed ID: 16630707
[TBL] [Abstract][Full Text] [Related]
15. The Psychosis Spectrum in 22q11.2 Deletion Syndrome Is Comparable to That of Nondeleted Youths.
Tang SX; Moore TM; Calkins ME; Yi JJ; Savitt A; Kohler CG; Souders MC; Zackai EH; McDonald-McGinn DM; Emanuel BS; Gur RC; Gur RE
Biol Psychiatry; 2017 Jul; 82(1):17-25. PubMed ID: 27832840
[TBL] [Abstract][Full Text] [Related]
16. Childhood maltreatment and transition to psychotic disorder independently predict long-term functioning in young people at ultra-high risk for psychosis.
Yung AR; Cotter J; Wood SJ; McGorry P; Thompson AD; Nelson B; Lin A
Psychol Med; 2015 Dec; 45(16):3453-65. PubMed ID: 26166153
[TBL] [Abstract][Full Text] [Related]
17. Dopamine in high-risk populations: A comparison of subjects with 22q11.2 deletion syndrome and subjects at ultra high-risk for psychosis.
Vingerhoets C; Bloemen OJN; Boot E; Bakker G; de Koning MB; da Silva Alves F; Booij J; van Amelsvoort TAMJ
Psychiatry Res Neuroimaging; 2018 Feb; 272():65-70. PubMed ID: 29174435
[TBL] [Abstract][Full Text] [Related]
18. Twelve-month psychosis-predictive value of the ultra-high risk criteria in children and adolescents.
Armando M; Pontillo M; De Crescenzo F; Mazzone L; Monducci E; Lo Cascio N; Santonastaso O; Pucciarini ML; Vicari S; Schimmelmann BG; Schultze-Lutter F
Schizophr Res; 2015 Dec; 169(1-3):186-192. PubMed ID: 26526751
[TBL] [Abstract][Full Text] [Related]
19. Psychotic conversion of individuals at ultra-high risk for psychosis: The potential roles of schizotypy and basic symptoms.
Bang M; Park JY; Kim KR; Lee SY; Song YY; Kang JI; Lee E; An SK
Early Interv Psychiatry; 2019 Jun; 13(3):546-554. PubMed ID: 29218852
[TBL] [Abstract][Full Text] [Related]
20. Basic symptoms in young people at ultra-high risk of psychosis: Association with clinical characteristics and outcomes.
Youn S; Phillips LJ; Amminger GP; Berger G; Chen EYH; de Haan L; Hartmann JA; Hickie IB; Lavoie S; Markulev C; McGorry PD; Mossaheb N; Nieman DH; Nordentoft M; Riecher-Rössler A; Schäfer MR; Schlögelhofer M; Smesny S; Thompson A; Verma S; Yuen HP; Yung AR; Nelson B
Schizophr Res; 2020 Feb; 216():255-261. PubMed ID: 31866077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
